Quick Takeaways
- Ares Trading S.A. has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $29,112,484.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Ares Trading S.A.
- Location
- Aubonne, Switzerland
- Summary
- The estimated value of insider holdings of Ares Trading S.A. is at least $29,112,484 dollars as of 14 Oct 2021. Ares Trading S.A. is the 10%+ Owner of PRECIGEN, INC. and owns shares of PRECIGEN, INC. (PGEN) stock worth about $29.11M.
- Signature
- /s/ Cedric Hyde, Authorized Signatory of Merck Serono SA
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Ares Trading S.A. and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
What Changed
- Largest disclosed position: PRECIGEN, INC. ($29,112,484).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Ares Trading S.A.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| PGEN | PRECIGEN, INC. | 10%+ Owner | $29,112,484 | 12 Oct 2021 | ||
| VERA | Vera Therapeutics, Inc. | 10%+ Owner | 13 May 2021 |
Insider Transactions Reported by Ares Trading S.A.:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.